ATC code C08 Calcium channel blockers is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup C08 is part of the anatomical group C Cardiovascular system.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QC08...[2]
- C08CA01 Amlodipine
- C08CA02 Felodipine
- C08CA03 Isradipine
- C08CA04 Nicardipine
- C08CA05 Nifedipine
- C08CA06 Nimodipine
- C08CA07 Nisoldipine
- C08CA08 Nitrendipine
- C08CA09 Lacidipine
- C08CA10 Nilvadipine
- C08CA11 Manidipine
- C08CA12 Barnidipine
- C08CA13 Lercanidipine
- C08CA14 Cilnidipine
- C08CA15 Benidipine
- C08CA55 Nifedipine, combinations
[edit] C08CX Other selective calcium channel blockers with mainly vascular effects
- C08CX01 Mibefradil
[edit] C08D Selective calcium channel blockers with direct cardiac effects
- C08DA01 Verapamil
- C08DA02 Gallopamil
- C08DA51 Verapamil, combinations
- C08DB01 Diltiazem
[edit] C08E Non-selective calcium channel blockers
[edit] C08EA Phenylalkylamine derivatives
- C08EA01 Fendiline
- C08EA02 Bepridil
[edit] C08EX Other non-selective calcium channel blockers
- C08EX01 Lidoflazine
- C08EX02 Perhexiline
[edit] C08G Calcium channel blockers and diuretics
[edit] C08GA Calcium channel blockers and diuretics
- C08GA01 Nifedipine and diuretics
[edit] References